A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Trial Identifier:	D5670C00003
Sponsor:	MedImmune, LLC
NCTID::	NCT03341013
Start Date:	November 2017
Primary Completion Date:	January 2018
Study Completion Date:	January 2018
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Spanish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, TX	Dallas, TX, United States of America, 75247

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.